← All diseases
Lungs and airways
Cystic fibrosis
Do you want to receive a message when there is new research about cystic fibrosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication there is one sentence that explains what was studied — and you receive notification as soon as there is new research on Cystic Fibrosis. View what Premium costs.
Publications and studies (2553)
- Effect of Disinfection Method and Testing Methodology on the Performance of a Breath-Enhanced Jet Nebulizer. (2023/12/21) ♡
- Club cell CREB regulates the goblet cell transcriptional network and pro-mucin effects of IL-1B. (2023/12/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Paralogue-Specific Roles of SUMO1 and SUMO2/3 in Protein Quality Control and Associated Diseases. (2023/12/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Caroli's Syndrome: A Case Report and Literature Review. (2023/12/20) ♡
- Protein expression changes in Tibetan middle-to-long distance runners after the transition from high altitude to low altitude: Implications for enhancing endurance training. (2023/12/20) ♡
- Global Burden of Cardiovascular Diseases and Risks, 1990-2022. (2023/12/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multiomics insights on the onset, progression, and metastatic evolution of breast cancer. (2023/12/19) ♡
- Optimizing CFTR modulator therapy management for cystic fibrosis through the ReX platform. (2023/12/19) ♡
- Virulence of Pseudomonas aeruginosa in Cystic Fibrosis: Relationships between Normoxia and Anoxia Lifestyle. (2023/12/19) ♡
- DNAJB11 Mutation in ADPKD Patients: Clinical Characteristics in a Monocentric Cohort. (2023/12/19) ♡
- Engineering the ChlorON Series: Turn-On Fluorescent Protein Sensors for Imaging Labile Chloride in Living Cells. (2023/12/18) ♡
- Strain-level characterization of health-associated bacterial consortia that colonize the human gut during infancy. (2023/12/17) ♡
- Low-intensity ultrasound activates transmembrane chloride flow through CFTR. (2023/12/17) ♡
- Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration system. (2023/12/15) ♡
- Gastroenterology services for patients with Cystic Fibrosis across Australia and New Zealand: a multi-stakeholder assessment of patients' and professionals' perspectives. (2023/12/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease. (2023/12/14) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Efficacy and safety profile of elexacaftor-tezacaftor-ivacaftor triple therapy on cystic fibrosis: a systematic review and single arm meta-analysis. (2023/12/14) ♡
- Acidic pH modulates Burkholderia cenocepacia antimicrobial susceptibility in the cystic fibrosis nutritional environment. (2023/12/12) ♡
- Plasma levels of chemokines decrease during elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis. (2023/12/12) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Severe Bicuspid Aortic Valve Disease in an Adult Cystic Fibrosis Patient. (2023/12/12) ♡
- Putting bicarbonate on the spot: pharmacological insights for CFTR correction in the airway epithelium. (2023/12/11) ♡
- Association Among Cystic Volume, Intracystic Pressure, and Histopathological Changes in the Liver in Patients With Choledochal Cyst. (2023/12/09) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. In Silico and In Vitro Evaluation of the Mechanism of Action of Three Vx809-based Hybrid Derivatives as Correctors of the F508del CFTR Protein. (2023/12/08) ♡
- Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension study. (2023/12/07) ♡
- Factors guiding gastrostomy tube decision-making for caregivers of children with cystic fibrosis: a scoping review protocol. (2023/12/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The current state of gastrointestinal motility evaluation in cystic fibrosis: a comprehensive literature review. (2023/12/06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Association between Dietary Intake and Faecal Microbiota in Children with Cystic Fibrosis. (2023/12/05) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Indwelling central venous catheter infection with Chryseobacterium shandongense - successful eradication in a 5-year-old with cystic fibrosis. (2023/12/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of CFTR channel in female infertility. (2023/12/01) ♡
- Pregnancy in women with cystic fibrosis and diabetes: An audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator era. (2023/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Refeeding Syndrome in Pediatric Age, An Unknown Disease: A Narrative Review. (2023/12/01) ♡
- Real-life experience with a generic formulation of lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for the Phe508del CFTR mutation. (2023/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Gastroesophageal reflux burden in youth with CF treated with elexacaftor-tezacaftor-ivacaftor. (2023/12/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Cross-Sectional Study of Pediatric Feeding Disorder in Children with Cystic Fibrosis. (2023/12/01) ♡
- Novel insect-based child nutrition: the position of the nutritional committee of the Italian society of pediatric gastroenterology, hepatology and nutrition (SIGENP). (2023/12/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effect of 18 months of elexacaftor-tezacaftor-ivacaftor on body mass index and glycemic control in adults with cystic fibrosis. (2023/12/01) ♡
- Atomistic modelling and NMR studies reveal that gallium can target the ferric PQS uptake system in P. aeruginosa biofilms. (2023/12/01) ♡
- Secretagogue effect of PDE4 inhibitor apremilast on human salivary gland organoids obtained from primary Sjögren's syndrome patients. (2023/12/01) ♡
- Association between sputum culture results and pulmonary changes in children with cystic fibrosis. (2023/12/01) ♡
- Comparison of culture and PCR-DGGE methods to evaluate the airways of cystic fibrosis patients and determination of their antibiotic resistance profile. (2023/12/01) ♡
- Integrating airway microbiome and blood proteomics data to identify multi-omic networks associated with response to pulmonary infection. (2023/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. The ageing of Cystic Fibrosis patients with new modulators: current gaps and challenges. (2023/12/01) ♡
- A prospective study to assess the impact of a novel CFTR therapy combination on body composition in patients with cystic fibrosis with F508del mutation. (2023/12/01) ♡
- Increased aminotransferases do not necessarily mean hepatotoxicity of CFTR modulator therapy. (2023/12/01) ♡
- Boolean model of the gene regulatory network of Pseudomonas aeruginosa CCBH4851. (2023/11/30) ♡
- Photodynamic Eradication of Pseudomonas aeruginosa with Ru Photosensitizers Encapsulated in Enzyme Degradable Nanocarriers. (2023/11/27) ♡
- Non-cystic fibrosis bronchiectasis: A single-centre retrospective study in Johannesburg, South Africa. (2023/11/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Bifidobacterium adolescentis - a beneficial microbe. (2023/11/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes. (2023/11/23) ♡
- 3,4-dimethoxychalcone induces autophagy and reduces neointimal hyperplasia and aortic lesions in mouse models of atherosclerosis. (2023/11/22) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.